Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MREO |
---|---|---|
09:32 ET | 19390 | 4.18 |
09:33 ET | 69893 | 4.13 |
09:35 ET | 1900 | 4.15 |
09:37 ET | 4550 | 4.1301 |
09:39 ET | 17925 | 4.21 |
09:42 ET | 100 | 4.215 |
09:44 ET | 200 | 4.215 |
09:46 ET | 6620 | 4.215 |
09:48 ET | 200 | 4.2339 |
09:50 ET | 700 | 4.215 |
09:51 ET | 400 | 4.204 |
09:53 ET | 600 | 4.215 |
09:55 ET | 2844 | 4.215 |
09:57 ET | 7650 | 4.23 |
10:00 ET | 303 | 4.24 |
10:02 ET | 100 | 4.225 |
10:04 ET | 2944 | 4.245 |
10:06 ET | 7600 | 4.27 |
10:08 ET | 100 | 4.25 |
10:09 ET | 1433 | 4.265 |
10:11 ET | 2200 | 4.285 |
10:13 ET | 10914 | 4.26 |
10:15 ET | 27283 | 4.225 |
10:18 ET | 100 | 4.22 |
10:20 ET | 4017 | 4.2 |
10:22 ET | 3990 | 4.18 |
10:24 ET | 4798 | 4.175 |
10:26 ET | 16106 | 4.14 |
10:27 ET | 11182 | 4.1603 |
10:29 ET | 4161 | 4.17 |
10:31 ET | 19621 | 4.145 |
10:33 ET | 2206 | 4.15 |
10:36 ET | 15274 | 4.15 |
10:38 ET | 13764 | 4.11 |
10:40 ET | 10814 | 4.0799 |
10:42 ET | 14800 | 4.065285 |
10:44 ET | 42824 | 4.0266 |
10:45 ET | 6146 | 4.048 |
10:47 ET | 12189 | 4.045 |
10:49 ET | 4743 | 4.0356 |
10:51 ET | 9640 | 4.045 |
10:54 ET | 11142 | 4.045 |
10:56 ET | 5483 | 4.065 |
10:58 ET | 3250 | 4.05 |
11:00 ET | 1631 | 4.04 |
11:02 ET | 5444 | 4.04 |
11:03 ET | 100 | 4.045 |
11:05 ET | 3191 | 4.035 |
11:07 ET | 2713 | 4.045 |
11:09 ET | 400 | 4.045 |
11:12 ET | 14199 | 4.03 |
11:14 ET | 1508 | 4.0598 |
11:16 ET | 1800 | 4.055 |
11:18 ET | 1700 | 4.06 |
11:20 ET | 3109 | 4.055 |
11:21 ET | 3224 | 4.0601 |
11:23 ET | 13340 | 4.055 |
11:25 ET | 1681 | 4.055 |
11:27 ET | 1400 | 4.055 |
11:32 ET | 500 | 4.055 |
11:34 ET | 11092 | 4.06 |
11:36 ET | 3094 | 4.07 |
11:38 ET | 5400 | 4.07 |
11:39 ET | 3129 | 4.07 |
11:41 ET | 3231 | 4.055 |
11:43 ET | 3476 | 4.04 |
11:45 ET | 670 | 4.045 |
11:48 ET | 2602 | 4.035 |
11:50 ET | 11945 | 4.04 |
11:52 ET | 1000 | 4.0384 |
11:54 ET | 10258 | 4.05 |
11:56 ET | 1300 | 4.06 |
11:57 ET | 3070 | 4.05 |
11:59 ET | 1800 | 4.05 |
12:01 ET | 6943 | 4.08 |
12:03 ET | 1216 | 4.0899 |
12:06 ET | 401 | 4.085 |
12:08 ET | 655 | 4.085 |
12:10 ET | 8364 | 4.09 |
12:12 ET | 323 | 4.085 |
12:14 ET | 200 | 4.085 |
12:15 ET | 9346 | 4.085 |
12:17 ET | 9655 | 4.08 |
12:21 ET | 10807 | 4.07 |
12:24 ET | 1100 | 4.07 |
12:26 ET | 3844 | 4.08 |
12:28 ET | 7132 | 4.105 |
12:30 ET | 445 | 4.1 |
12:32 ET | 1000 | 4.105 |
12:33 ET | 100 | 4.11 |
12:35 ET | 326 | 4.105 |
12:37 ET | 2022 | 4.1057 |
12:39 ET | 226 | 4.11 |
12:42 ET | 2100 | 4.1076 |
12:44 ET | 300 | 4.09 |
12:46 ET | 2589 | 4.095 |
12:48 ET | 712 | 4.095 |
12:50 ET | 4728 | 4.1 |
12:51 ET | 400 | 4.0949 |
12:53 ET | 304 | 4.095 |
12:55 ET | 226 | 4.095 |
12:57 ET | 5872 | 4.0993 |
01:00 ET | 2233 | 4.06 |
01:02 ET | 250 | 4.0684 |
01:06 ET | 2314 | 4.065 |
01:08 ET | 8749 | 4.08 |
01:09 ET | 7580 | 4.06 |
01:11 ET | 1200 | 4.051 |
01:13 ET | 4353 | 4.07 |
01:20 ET | 10072 | 4.1 |
01:22 ET | 3098 | 4.08 |
01:24 ET | 300 | 4.075 |
01:26 ET | 10864 | 4.0807 |
01:27 ET | 2572 | 4.075 |
01:31 ET | 1288 | 4.08 |
01:33 ET | 100 | 4.075 |
01:36 ET | 100 | 4.0789 |
01:38 ET | 1100 | 4.07 |
01:40 ET | 950 | 4.08 |
01:44 ET | 7200 | 4.0764 |
01:45 ET | 478 | 4.075 |
01:47 ET | 4492 | 4.07 |
01:49 ET | 1577 | 4.07 |
01:51 ET | 1000 | 4.07 |
01:54 ET | 1100 | 4.07 |
01:56 ET | 3600 | 4.07 |
01:58 ET | 1070 | 4.075 |
02:00 ET | 316 | 4.075 |
02:02 ET | 100 | 4.08 |
02:03 ET | 2438 | 4.09 |
02:05 ET | 300 | 4.085 |
02:07 ET | 408 | 4.085 |
02:09 ET | 427 | 4.085 |
02:12 ET | 2897 | 4.07 |
02:14 ET | 1424 | 4.08 |
02:16 ET | 2249 | 4.09 |
02:20 ET | 2679 | 4.08 |
02:21 ET | 2909 | 4.075 |
02:23 ET | 5000 | 4.08 |
02:25 ET | 417 | 4.075 |
02:27 ET | 694 | 4.075 |
02:32 ET | 1513 | 4.075 |
02:34 ET | 400 | 4.075 |
02:36 ET | 500 | 4.075 |
02:38 ET | 5519 | 4.075 |
02:39 ET | 3038 | 4.085 |
02:41 ET | 1779 | 4.095 |
02:43 ET | 944 | 4.1 |
02:45 ET | 2131 | 4.095 |
02:50 ET | 1298 | 4.1 |
02:52 ET | 252 | 4.095 |
02:54 ET | 300 | 4.095 |
02:56 ET | 558 | 4.095 |
02:57 ET | 6841 | 4.095 |
02:59 ET | 1662 | 4.1 |
03:01 ET | 200 | 4.1 |
03:03 ET | 900 | 4.105 |
03:06 ET | 171 | 4.1 |
03:08 ET | 9629 | 4.105 |
03:10 ET | 4431 | 4.1 |
03:12 ET | 3376 | 4.105 |
03:14 ET | 1600 | 4.105 |
03:15 ET | 4348 | 4.105 |
03:17 ET | 1100 | 4.105 |
03:19 ET | 367 | 4.105 |
03:21 ET | 1605 | 4.11 |
03:24 ET | 200 | 4.115 |
03:28 ET | 7670 | 4.105 |
03:30 ET | 652 | 4.105 |
03:32 ET | 400 | 4.105 |
03:33 ET | 343 | 4.105 |
03:35 ET | 7052 | 4.1 |
03:37 ET | 2358 | 4.095 |
03:39 ET | 100 | 4.095 |
03:42 ET | 4139 | 4.105 |
03:44 ET | 400 | 4.11 |
03:46 ET | 2370 | 4.111 |
03:48 ET | 2563 | 4.12 |
03:50 ET | 4500 | 4.11 |
03:51 ET | 1645 | 4.115 |
03:53 ET | 11820 | 4.12 |
03:55 ET | 4564 | 4.125 |
03:57 ET | 7971 | 4.125 |
04:00 ET | 53598 | 4.1 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Mereo BioPharma Group PLC | 658.5M | -15.5x | --- |
Mind Medicine (MindMed) Inc | 657.8M | -3.6x | --- |
Opthea Ltd | 664.2M | -1.4x | --- |
AnaptysBio Inc | 681.6M | -3.5x | --- |
Astria Therapeutics Inc | 668.6M | -4.8x | --- |
Savara Inc | 669.9M | -8.9x | --- |
Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). In addition to the rare disease programs, it has two oncology product candidates in clinical development. Etigilimab is an IgG1 monoclonal antibody which binds to the human T-cell immunoreceptor with Ig and ITIM domains (TIGIT) receptor on immune cells to improve the activation and effectiveness of T-cell and NK cell antitumor activity. Navicixizumab is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Navicixizumab is developed for the treatment of late line ovarian cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $658.5M |
---|---|
Revenue (TTM) | $1.2M |
Shares Outstanding | 153.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.99 |
EPS | $-0.26 |
Book Value | $0.36 |
P/E Ratio | -15.5x |
Price/Sales (TTM) | 543.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,918.95% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.